Proceedings of the Texas A&M Medical Student Grand Rounds

The Therapeutic Implications of Copper-Yeast Chaperone in Sod1 Folding in Familial ALS

July 7, 2020 Farah Wazir

Farah Wazir

Introduction. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a neurodegenerative disease resulting in the loss of alpha motor neurons in the brain and spinal cord with no cure.1,2 ALS results in difficulty controlling voluntary muscles and the eventual muscular paralysis.1 ALS patients present with atrophy and spasticity and have a poor prognosis.1 Familial ALS (fALS) arises primarily from a genetic origin involving major genes, including the superoxide dismutase 1 (Sod1) gene.3 Sod1 is a copper/zinc superoxide dismutase enzyme that converts superoxide radicals into oxygen and hydrogen peroxide and binds zinc and copper metal ions for proper maturation.1 A copper chaperone (Ccs) promotes Sod1 protein maturation through facilitation of post-translational modifications.4 Sod1 gene mutations result in misfolded Sod1 protein in motor neurons and the accumulation of hydroxyl radicals leading to DNA damage.1 Studies have found that Sod1 mutations hinder Ccs-mediated Sod1 maturation and affect zinc-binding affinities.5 Other studies have shown Ccs restores the maturation of Sod1 fALS mutants through the formation of stable Ccs-Zn complexes.6 These findings suggest a potential therapeutic target in Ccs mechanisms and metal ions in the proper folding of Sod1. Methods. The yeast form of Ccs and human form of Sod1 were utilized.5 Site-specific amino acid changes A4V, H80R, G85R, and G93A were done via quick-change mutagenesis to generate fALS-Sod1 mutants.5 Sod1 and Ccs proteins were expressed and purified.5 Purified ALS-Sod1 and Ccs protein samples were run on SDS-PAGE gels and visualized with Coomassie stain.5 Sod1 was fluorescently labeled and microplate binding assays were prepared.6 Equilibrium dialysis was used to measure Zn affinity values of isolated Sod1 mutants and mutant Sod1-Ccs complexes.5 Zinc binding affinities were quantified using dissociation constants (Kd).5 Results. The interaction of Ccs with fALS-Sod1 mutants was not significantly hindered.5 Ccs binding prevents oligomerization and insoluble aggregation in vitro of WT-like Sod1 mutants.5 Zinc dissociation constants for each fALS-Sod1 mutant differed at each stage of Sod1 maturation.5 Ccs was shown to have little effect on Zn affinity in G93A and G85R Sod1 mutants.5 A4V Sod1 mutant showed decreased Zn affinity with each stage of maturation.5 Conclusions. Studies show that fALS-Sod1 mutants have worse zinc-binding affinities than in WT Sod1 protein and provide a foundation for future studies in this field. These results indicate a significant role of copper-yeast chaperone in the proper acquisition of zinc in the maturation of Sod1 and a potential therapeutic target in fALS-Sod1 pathology.

  1. Workman A. Nucleation and kinetics of Sod1 aggregation in human cells for ALS1. Mol Cell Biochem. 2020;466(1-2):117-128. doi:10.1007/s11010-020-03693-y
  2. Kaur S, McKeown S, Rashid S. Mutant Sod1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. Gene. 2016;577(2):109-118. doi:10.1016/j.gene.2015.11.049
  3. Pansarasa O, Bordoni M, Diamanti L, Sproviero D, Gagliardi S, Cereda C. Sod1 in Amyotrophic Lateral Sclerosis: “Ambivalent” Behavior Connected to the Disease. Int J Mol Sci. 2018;19(5):1345. doi:10.3390/ijms19051345
  4. Fetherolf M, Boyd S, Taylor A et al. Copper-zinc superoxide dismutase is activated through a sulfenic acid intermediate at a copper ion entry site. J Biol Chem.  2017;292(29):12025-12040. doi:10.1074/jbc.m117.775981
  5. Boyd S, Ullrich M, Calvo J, Behnia F, Meloni G, Winkler D. Mutations in Superoxide Dismutase 1 (Sod1) Linked to Familial Amyotrophic Lateral Sclerosis Can Disrupt High-Affinity Zinc-Binding Promoted by the Copper Chaperone for Sod1 (Ccs). Molecules. 2020;25(5):1086. doi:10.3390/molecules25051086
  6. Luchinat E, Barbieri L, Banci L. A molecular chaperone activity of CCS restores the maturation of Sod1 fALS mutants. Sci Rep. 2017;7(1). doi:10.1038/s41598-017-17815-y

 

 

 

Neuroscience
Previous Post

Mechanisms of Increased ERalpha+ Breast Cancer Risk Due to Alcohol Consumption

Next Post

Human Induced Pluripotent Stem Cells as a Treatment for Parkinson’s Disease

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.